These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Stent thrombosis in the era of drug eluting stents. Kawaguchi R; Angiolillo DJ; Futamatsu H; Suzuki N; Bass TA; Costa MA Minerva Cardioangiol; 2007 Apr; 55(2):199-211. PubMed ID: 17342038 [TBL] [Abstract][Full Text] [Related]
7. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation. Garg P; Mauri L Curr Opin Cardiol; 2007 Nov; 22(6):565-71. PubMed ID: 17921745 [TBL] [Abstract][Full Text] [Related]
8. Understanding the drug-eluting stent trials. Coolong A; Kuntz RE Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349 [TBL] [Abstract][Full Text] [Related]
9. Antiplatelet therapy following drug-eluting stent implantation: new clinical data and recommendations. Paradis JM; Ducrocq G; Tanguay JF Minerva Cardioangiol; 2008 Feb; 56(1):139-54. PubMed ID: 18432176 [TBL] [Abstract][Full Text] [Related]
10. Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis? Kumbhani DJ; Bavry AA; Bhatt DL Indian Heart J; 2007; 59(2 Suppl B):B113-7. PubMed ID: 19153427 [TBL] [Abstract][Full Text] [Related]
11. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries. Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Slottow TL; Xue Z; Torguson R; Kaneshige K; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R Am J Cardiol; 2009 Feb; 103(4):496-500. PubMed ID: 19195509 [TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications. Qasim A; Cosgrave J; Latib A; Colombo A Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358 [TBL] [Abstract][Full Text] [Related]
13. Incidence of thrombosis after implantation of drug-eluting stents in patients with coronary artery disease. Chen JL; Yang YJ; Gao LJ; Huang JH; Qin XW; Qiao SB; Xu B; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL Chin Med J (Engl); 2008 Nov; 121(21):2144-7. PubMed ID: 19080174 [TBL] [Abstract][Full Text] [Related]
14. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents. Spinler SA Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808 [TBL] [Abstract][Full Text] [Related]
15. [Optimal platelet inhibition after coronary stent implantation. Current status]. Silber S; Hoffmeister HM; Bode C Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073 [TBL] [Abstract][Full Text] [Related]
16. XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent. Beijk MA; Piek JJ Expert Rev Med Devices; 2007 Jan; 4(1):11-21. PubMed ID: 17187467 [TBL] [Abstract][Full Text] [Related]
18. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508 [TBL] [Abstract][Full Text] [Related]
19. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Lüscher TF; Steffel J; Eberli FR; Joner M; Nakazawa G; Tanner FC; Virmani R Circulation; 2007 Feb; 115(8):1051-8. PubMed ID: 17325255 [TBL] [Abstract][Full Text] [Related]
20. Status of drug-eluting coronary stents. Chodosh A; Korr KS; Burtt D Med Health R I; 2008 Oct; 91(10):309-12, 314. PubMed ID: 19044106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]